Table 1

Characteristics of the FINRISK97 study population

AllMenWomen
Baseline characteristics
 Age (years) mean (SD)48.79 (22.08)49.95 (23.03)47.55 (21.24)
 Male gender n (%)4225 (50.8)4225 (100)0 (0)
Cardiovascular risk factors
 Current smokers n (%)2139 (25.72)1302 (30.8)837 (20.5)
 Former smokers n (%)1821 (21.9)1248.2 (29.52)573 (14.02)
 Hypertensive_AHA n (%)3810 (45.8)2261 (53.5)1549 (37.9)
 History of diabetes mellitus n (%)488 (5.9)274 (6.5)214 (5.2)
 Systolic blood pressure (mmHg) mean (SD)134 (27)137 (26)130 (27)
 Body Mass Index (kg/m²) mean (SD)26.15 (5.62)26.62 (4.88)25.48 (6.38)
 Total cholesterol (mmol/L) median IQR5.47 (1.39)5.5 (1.36)5.43 (1.43)
 HDL (mmol/L) median IQR1.34 (0.48)1.22 (0.4)1.51 (0.47)
Endpoints during 15 years of follow-up
 Cardiovascular disease n (%)914 (11)650 (15.4)264 (6.5)
 Myocardial infarction n (%)359 (4.3)266 (6.3)93 (2.3)
 Coronary heart disease n (%)665 (8)499 (11.8)166 (4.1)
 Stroke (%)401 (4.8)273 (6.5)128 (3.1)
 Heart failure n (%)641 (7.7)383 (9.1)258 (6.3)
 MACE n (%)1183 (14.2)781 (18.5)402 (9.8)
 Death n (%)1136 (13.7)792 (18.7)344 (8.4)
Biomarkers
 ST2 (ng/ml) median (IQR)26.95 (13.7)30.4 (14.87)23.9 (11.09)
 NTproBNP (pg/mL) median (IQR)44.32 (64.38)31.63 (57.37)55.79 (64.17)
 eGFR91.93 (32.5)80.69 (21.48)108.17 (25.23)
 hsTroponin (pg/mL), median (IQR)3.1 (2.9)3.6 (3.27)2.6 (2.4)